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Purified 5-lipoxygenase from potato tubers was inhibited strongly by vitamin E and its analogs. The inhibi- 
tion by d-a-tocopherol was found to be irreversible and non-competitive with respect to arachidonic acid. 
An IC,, of 5 PM was calculated for d-a-tocopherol. The inhibition appears to be unrelated to its antioxidant 
function. Binding studies with W-labelled d-a-tocopherol revealed that there is a strong interaction between 
vitamin E and Slipoxygenase. Tryptic digestion and peptide mapping of 5-lipoxygenase-vitamin E complex 
indicate that vitamin E binds strongly to a single peptide. These studies suggest that cellular vitamin E levels 
may have profound influence on the formation of leukotrienes. 
5-Lipoxygenase Vitamin E cc-Tocopherol 
1. INTRODUCTION 
Vitamin E, as an integral part of membranes, is 
visualized as a biological antioxidant which by se- 
questering free radicals functions to terminate the 
propagation of autooxidation processes such as 
lipid peroxidation [l-3]. Important to this discus- 
sion is the fact that enzymatically regulated lipid 
peroxidation is associated with polyenoic fatty acid 
metabolism via the lipoxygenase(s) and cycloox- 
ygenase pathways. The immediate oxygenation 
products of these pathways are hydroperoxides 
and cyclic endoperoxides respectively, which are 
further metabolized to various biologically active 
compounds like leukotrienes, prostaglandins, 
prostacyclins and thromboxanes. It is well recog- 
nized that free radicals are generated during en- 
zymatic oxidation of arachidonic acid. Therefore, 
it is conceivable that modulation of radical pro- 
duction by antioxidants like vitamin E could serve 
as regulatory mechanism(s) in arachidonic acid 
cascade. Although the precise mechanism is still 
under investigation, recent reports indicate that 
vitamin E plays an important role in the modula- 
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tion of enzyme activities as well as the product pro- 
file of arachidonic acid cascade [4-81. More recent- 
ly, Grossman and Waksman [9] have shown that 
15-lipoxygenase is inhibited by vitamin E via a 
specific interaction with the enzyme. To our 
knowledge, such studies with 5-lipoxygenase, a 
pivotal enzyme in leukotriene biosynthesis, have 
not been undertaken. This may be partly due to 
stability problems associated with 5-lipoxygenase 
in the past. Here, we demonstrate that 5-lipoxy- 
genase from potato tubers is inhibited strongly by 
vitamin E. Also, we provide some evidence to 
show that there might be a specific interaction of 
vitamin E with 5-lipoxygenase. 
2. EXPERIMENTAL 
2.1. Materials 
Arachidonic acid (99070 pure), nordihydroguaiar- 
etic acid (NDGA) and butylated hydroxytoluene 
(BHT) were purchased from Sigma (St. Louis, 
MO); d-cu-tocopherol, d-cu-tocopherol acetate, d-y- 
tocopherol and d-cu-tocopherol quinone from 
Eastman Kodak, Rochester, NY; 14C-labelled -cu- 
tocopherol acetate was kindly provided by Dr L. J. 
Machlin, Hoffman La Roche Inc., Nutley, NJ; the 
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conversion of tocopherol acetate to free to- 
copherol was carried out by the method of Duggan 
[lo] prior to its use; fresh red potato tubers were 
obtained from local farmer’s markets. 
2.2. ~rificfftion of S-l~poxy~enffse 
Arachidonate 5-lipoxygenase was purified from 
potato tubers by a modification of the procedure 
of Sekiya et al. 1111. A brief description of the 
purification is as follows: a protamine sulfate 
treatment (0.1%) step was included prior to the 
ammonium sulfate fractionation (15-45%). The 
5-lipoxygenase was further purified by a combina- 
tion of conventional chromatographic and high- 
pressure liquid chromatographic steps employing 
hydrophobic interaction and anion-exchange 
phenomena. The final lipoxygenase preparation 
thus obtained was found to be greater than 99% 
pure as judged by analytical and SDS gel elec- 
trophoresis as well as by analytical isoelectric 
focusing. Details of the purification procedure and 
molecular properties of the enzyme will be pub- 
lished elsewhere. 
2.3. Assay of 54ipoxygenase 
The lipoxygenase activity was monitored polaro- 
graphically by an oxygen monitor (YSI model 53, 
Yellow Springs Instrument, Yellow Springs, OH). 
The assay mixture consisted of 0.1 M potassium 
phosphate, pH 6.3, lo-100 pg enzyme and 0.13 
mM arachidonic acid (in ethanol) in a total volume 
of 3.0 ml. The reaction was initiated by the addi- 
tion of arachidonic acid and incubated at 30°C. 
One unit of enzyme activity was defined as the 
amount of enzyme that produced 1 pmol %hydro- 
peroxyeicosatetraenoic acid (5-HPETE) or that 
consumed 1 pmol oxygen per min at 30°C. The 
specific activity was expressed as number of units 
per mg protein. The protein concentration was 
determined either by the spectrophotometric 
method of Warburg and Christian [12] or by the 
method of Lowry et al. [ 131. 
2.4. Inhibition studies 
Freshly prepared d-cu-tocopherol and its analogs 
in ethanol were used in these experiments, The en- 
zyme was preincubated with the inhibitor for 1 min 
prior to initiation of the reaction by the addition of 
arachidonic acid. The lipoxygenase reaction was 
monitored as described earlier. For all kinetic 
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studies of inhibition, the initial reaction velocities 
were determined in the presence of varying concen- 
trations of inhibitors while the concentration of 
arachidonic acid was held constant. Identical 
determinations were made in the presence of fixed 
concentrations of inhibitors with varying concen- 
trations of arachidonic acid. Data were analyzed 
by double-reciprocal plots. The ICSO was deter- 
mined by linear-regression analysis. 
2.5. d-a- Tocopherol binding experiments 
For binding studies, 5lipoxygenase (3 mg) was 
incubated with 100 pg d++ocopherol containing 
r4C-1abelled -tu-tocopherol (1 S-l .7 x 10” cpm) 
for 10 min at 25°C in a total volume of 3.0 ml of 
25 mM potassium phosphate buffer, pH 6.3. At 
the end of incubation, unbound d-cu-tocopherol 
was removed by gel filtration on a Sephadex G-15 
column. 
Tryptic digestions were carried out in 3-ml ali- 
quots consisting of 0.5 mg protein-vitamin E com- 
plex recovered from Sephadex G-15 column 
chromatography, 100 pg trypsin and 50 mM Tris- 
HCl, pH 8.0 for 24 h at 37°C. Primary peptide 
separation was achieved by gel filtration on a 
Sephadex G-15 column. Absorbance of the ef- 
fluent was monitored at 220 nm. Radioactivity of 
individual fractions was determined by liquid scin- 
tillation spectrometry. The fractions containing 
radioactivity were pooled and subjected to HPLC 
analysis on a C-l 8 pBondapak reversed-phase col- 
umn (10 pm, 4 mm x 30 cm) employing a Waters 
Associates (Milford, MA) 272 microprocessor- 
controlled gradient system consisting of an M720 
system controller along with M6OOOA pumping, 
and U6K universal injection system. Elution of 
peptides was achieved by the use of a linear gra- 
dient, from 0.1% trifluoroacetic acid (TFA) in 
water to 0.1% TFA and 70% acetonitrile in water 
at a constant flow rate of 1 ml/min. The radioac- 
tivity of the effluent fractions was determined by 
liquid scintillation spectrometry. 
3. RESULTS AND DISCUSSION 
The effect of vitamin E and its analogs on 
5-lipoxygenase was studied with a purified enzyme 
(90-95% pure) from potato tubers. For com- 
parison, the effect of BHT and NDGA, known in- 
hibitors of lipoxygenases, was also investigated. As 
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shown in table 1, d-cu-tocopherol was found to be 
a potent inhibitor of Slipoxygenase. The inhibi- 
tion was concentration dependent with an ICSO 
value of 5 PM. A similar inhibitory pattern was 
observed with d-y-tocopherol which suggests that 
the inhibition is not specific for natural isomer of 
vitamin E. The inhibition by d-c+tocopherol was 
found to be irreversible and non-competitive with 
respect to arachidonic acid. Interestingly, d-cu- 
tocopherol acetate and d-cu-tocopherol quinone ex- 
hibited an inhibitory effect on Slipoxygenase, 
Table 1 
Effects of vitamin E and its analogs on S-lipoxygenase 
activity” 
Inhibitor Concen- Specific % inhibi- 
tration activity tion 
01M) 
None - 11.0 0 
Ethanolb I 12.0 0 
3 10.0 10 
5 6.0 50 
d-a-Tocopherol 1 9.2 17.0 
5 6.1 45.0 
10 3.9 65.0 
100 0.6 95.0 
d-a-Tocopherol 1 10.5 5.0 
acetate 5 9.2 17.0 
10 8.3 25.0 
100 5.7 48.0 
d-y-Tocopherol 1 7.7 30.0 
5 3.5 68.0 
10 3.1 72.0 
100 0.8 92.0 
d-a-Tocopherol 1 9.9 10.0 
quinone 5 8.4 23.0 
10 8.3 25.0 
100 4.8 57.0 
BHT 1 6,l 45.0 
5 3.0 73.0 
10 2.9 73.0 
100 2.0 82.0 
NDGA 1 3.7 67.0 
5 2.2 80.0 
10 1.7 85.0 
100 0.7 93.0 
a Values given for specific activity are the averages of 3 
separate experiments. individual values among the 3 
experiments were within 5% variation 
b Concentration of ethanol in the reaction mixtures are 
given as percentage solutions 
although to a lesser extent. This is somewhat sur- 
prising because the latter 2 vitamin E analogs are 
known to be poor antioxidants. These results sug- 
gest that the inhibition of Slipoxygenase by 
vitamin E and its analogs is probably not related to 
their antioxidant function. Our observations with 
Slipoxygenase are quite agreeable with the recent 
findings of Grossman and Waksman f9] on 15 
lipoxygenase. However, our results differ from 
theirs in that d-cY-tocopherol and d-cu-tocopherol 
acetate do not inhibit 5-lipoxygenase to the same 
extent whereas they were found to be equipotent 
on 1Slipoxygenase. It should be noted that many 
of these inhibitors are not water soluble, therefore, 
ethanol was employed as a vehicle. However, 
ethanol by itself caused significant inhibition 
(- 50%) of 5-lipoxygenase activity at concentra- 
tions of 5% and above. Therefore, ethanol concen- 
trations were not allowed to be higher than lolo in 
our reaction mixtures. 
As expected, BHT and NDGA inhibited Slipoxy- 
genase very potently. But the interesting aspect of 
our studies is the fact that the concentrations of 
vitamin E required to inhibit the enzyme are within 
l/10 of BHT and NDGA. Furthermore, these 
values appear to be within the physiological range 
of cellular vitamin E levels. For example, in certain 
tissues like lung, heart, testes and liver, the local 
concentrations of vitamin E within the subcellular 
organelles of cell are reported to be in the micro- 
molar range f14]. Therefore, it is quite conceivable 
that the 5-lipoxygenase activity in those tissues, 
particularly lung, might be under check by vitamin 
E. Thus, tissue vitamin E levels may exert pro- 
found influence on the formation of leukotrienes, 
main products of Slipoxygenase pathway. How- 
ever, experimental evidence reIating vitamin E 
levels and leukotriene formation needs to be 
generated before one can draw definite conclusions 
on the modulatory role of vitamin E in leukotriene 
biosynthesis. 
Grossman and Waksman [9] have reported that 
vitamin E inhibits 15-lipoxygenase via a specific in- 
teraction with the enzyme protein. We have in- 
vestigated the possibility that vitamin E might be 
inhibiting 5-lipoxygenase by such an interaction 
with the protein. This was tested by incubating 
t4C-labelled d-cr-tocopherol with 5-lipoxygenase 
and the unbound radioactive d-o-tocopherol was 
separated by gel filtration. The results of d-cr- 
41 
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Fig. 1. Gel filtration of 5-lipoxygenase-d-Lu-[‘4C]tocopherol mixture on Sephadex G-15 column. 
tocopherol binding studies are illustrated in fig.1. 
It is evident from the figure that the radioactivity 
peak and protein peak were co-eluted in the void 
volume of the Sephadex G-15 column which in- 
dicated that there was formation of a complex be- 
tween vitamin E and 5lipoxygenase. The nature of 
binding of vitamin E to the enzyme was further 
tested by repeated extraction of the pooled fraction 
between elution volumes 20 and 35 (fig.1) with 
ethyl acetate. Most of the radioactivity was re- 
covered in the aqueous phase suggesting that 
vitamin E binds strongly to 5lipoxygenase. To 
analyze further the binding pattern; the vitamin E- 
enzyme complex was subjected to tryptic digestion 
for 24 h and the resulting mixture of peptides was 
analyzed by a combination of gel filtration on 
Sephadex G-15 and HPLC on a reversed-phase 
column (fig.2). As shown in fig.2, all the radioac- 
tivity was recovered in a larger M, peptide. Upon 
HPLC analysis (inset, fig.2), it was found that the 
entire radioactivity was associated with one pep- 
tide only. Studies are currently in progress in our 
laboratory to investigate the specific amino acid 
with which vitamin E is binding. 
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Fig. 1. Gel filtration of tryptic digestion products of 5-lipoxygenase-vitamin E complex on Sephadex G-15 column. Inset: 
further analysis of radioactivity containing peptide fraction on a reversed-phase HPLC column. 
43 
